Craig Thomas

34PUBLICATIONS
273CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsToxicology (incl. clinical toxicology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Apr 17, 2026
Ubiquitin-dependent recruitment of SLFN11 to chromatin is regulated by deubiquitinase (DUB) and RNF168.

|Feb 11, 2026
Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant Rhabdomyosarcoma.

Patience Odeniyide, Alyza Skaist, Elizabeth Fenner

|Dec 18, 2025
An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors.

Ana Corrionero, Xiaohu Zhang, Patricia Alfonso

|Oct 08, 2025
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer.

Juan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo

|Oct 03, 2025
Multiple Epigenetic Mechanisms Functionally Cooperate to Silence Expression of Somatostatin Receptor Type 2 in Pancreatic Neuroendocrine Tumors.

James P Madigan, Stephen G Andrews, Rivka B Farrell

|Aug 14, 2025
The Kinase Inhibitor GNF-7 Is Synthetically Lethal in Topoisomerase 1-Deficient Ewing Sarcoma.

Carly M Sayers, Morgan B Carter, Haiyan Lei

Pageof 6

Frequent Collaborators

9 joint publications

Kelli Wilson

7 joint publications

Michele Ceribelli

6 joint publications

Carleen Klumpp-Thomas

6 joint publications

Xiaohu Zhang